HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.

Abstract
Multidrug resistance (MDR) is characterized by the overexpression of ATP-binding cassette (ABC) transporters that actively pump a broad class of hydrophobic chemotherapeutic drugs out of cancer cells. MDR is a major mechanism of treatment resistance in a variety of human tumors, and clinically applicable strategies to circumvent MDR remain to be characterized. Here we describe the fabrication and characterization of a drug-loaded iron oxide nanoparticle designed to circumvent MDR. Doxorubicin (DOX), an anthracycline antibiotic commonly used in cancer chemotherapy and substrate for ABC-mediated drug efflux, was covalently bound to polyethylenimine via a pH sensitive hydrazone linkage and conjugated to an iron oxide nanoparticle coated with amine terminated polyethylene glycol. Drug loading, physiochemical properties and pH lability of the DOX-hydrazone linkage were evaluated in vitro. Nanoparticle uptake, retention, and dose-dependent effects on viability were compared in wild-type and DOX-resistant ABC transporter over-expressing rat glioma C6 cells. We found that DOX release from nanoparticles was greatest at acidic pH, indicative of cleavage of the hydrazone linkage. DOX-conjugated nanoparticles were readily taken up by wild-type and drug-resistant cells. In contrast to free drug, DOX-conjugated nanoparticles persisted in drug-resistant cells, indicating that they were not subject to drug efflux. Greater retention of DOX-conjugated nanoparticles was accompanied by reduction of viability relative to cells treated with free drug. Our results suggest that DOX-conjugated nanoparticles could improve the efficacy of chemotherapy by circumventing MDR.
AuthorsForrest M Kievit, Freddy Y Wang, Chen Fang, Hyejung Mok, Kui Wang, John R Silber, Richard G Ellenbogen, Miqin Zhang
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 152 Issue 1 Pg. 76-83 (May 30 2011) ISSN: 1873-4995 [Electronic] Netherlands
PMID21277920 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2011 Elsevier B.V. All rights reserved.
Chemical References
  • Antibiotics, Antineoplastic
  • Ferric Compounds
  • ferric oxide
  • Polyethylene Glycols
  • Doxorubicin
  • Polyethyleneimine
Topics
  • Animals
  • Antibiotics, Antineoplastic (administration & dosage)
  • Brain Neoplasms (drug therapy)
  • Cell Line, Tumor
  • Doxorubicin (administration & dosage, chemistry, pharmacokinetics)
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Ferric Compounds (administration & dosage, chemistry)
  • Glioma (drug therapy)
  • Hydrogen-Ion Concentration
  • Metal Nanoparticles (administration & dosage, chemistry)
  • Particle Size
  • Polyethylene Glycols (chemistry)
  • Polyethyleneimine (chemistry)
  • Rats
  • Solubility
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: